TCMD TACTILE SYSTEMS TECHNOLOGY INC
Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1027838 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY14.4%
TTM net income YoY31.1%
TTM EPS YoY35.5%
Revenue 3-yr CAGR9.6%
Net income 3-yr CAGR-1.5%
Margins
Gross margin77.0%
Operating margin9.4%
Net margin6.7%
FCF margin8.1%
EBITDA margin11.4%
Returns
ROE11.0%
ROA8.7%
ROIC (approx.)15.3%
Asset turnover1.29x
Leverage & solvency
Liabilities / assets22.0%
Debt / equity0.00x
Current ratio3.51x
Interest coverage431.51x
Cash quality & payout
Operating cash flow / net income1.35x
Accruals ratio-3.0%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $91.86M | $85.70M | $75.27M | $103.59M | $85.75M | $78.91M | $61.27M | $85.58M |
| Cost of revenue | $21.37M | $20.35M | $17.65M | $22.59M | $20.75M | $20.11M | $15.92M | $21.22M |
| Gross profit | $70.49M | $65.35M | $57.61M | $81.01M | $65.00M | $58.79M | $45.35M | $64.37M |
| R&D expense | $2.51M | $2.50M | $2.78M | $2.53M | $2.19M | $2.02M | $1.74M | $2.04M |
| SG&A expense | $24.66M | $23.36M | $23.04M | $25.23M | $21.44M | $22.03M | $20.00M | $19.98M |
| Operating income | $9.59M | $6.83M | -$1.53M | $18.77M | $10.96M | $4.08M | -$4.54M | $12.52M |
| Interest expense | $20,000 | $19,000 | $28,000 | $11,000 | $193,000 | $410,000 | $424,000 | $471,000 |
| Pretax income | $10.13M | $7.37M | -$896,000 | $19.45M | $11.44M | $4.52M | -$4.07M | $12.99M |
| Income tax | $2.97M | -$417,000 | $867,000 | $8.81M | $3.23M | $1.31M | -$1.10M | $3.27M |
| Net income | $7.16M | $7.79M | -$1.76M | $10.63M | $8.21M | $3.22M | -$2.97M | $9.72M |
| EBITDA | $11.36M | $8.64M | $105,000 | $20.39M | $12.60M | $5.74M | -$2.82M | $14.23M |
| EPS (basic) | 0.32 | 0.34 | -0.08 | — | 0.37 | 0.14 | -0.13 | — |
| EPS (diluted) | 0.31 | 0.34 | -0.08 | — | 0.36 | 0.14 | -0.13 | — |
| Weighted avg. shares (diluted) | 23.05M | 23.06M | 22.56M | — | 22.51M | 23.24M | 23.71M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $75.11M | $69.85M | $74.99M | $83.45M | $65.97M | $81.53M | $83.62M | $94.37M |
| Receivables | $48.30M | $43.14M | $38.22M | $43.88M | $37.26M | $33.09M | $35.69M | $44.94M |
| Inventory | $15.60M | $16.84M | $16.58M | $14.03M | $16.08M | $17.11M | $18.87M | $18.67M |
| Current assets | $166.78M | $157.60M | $152.84M | $165.17M | $141.40M | $152.99M | $160.12M | $177.56M |
| PP&E, net | $5.68M | $5.85M | $5.20M | $5.12M | $5.46M | $4.90M | $5.39M | $5.60M |
| Goodwill | $39.55M | $39.55M | $39.55M | $31.06M | $31.06M | $31.06M | $31.06M | $31.06M |
| Intangibles | $43.72M | $44.75M | $42.31M | $39.17M | $40.02M | $40.90M | $41.87M | $42.79M |
| Total assets | $291.29M | $279.67M | $272.12M | $273.94M | $259.18M | $273.05M | $280.24M | $297.92M |
| Current liabilities | $47.50M | $38.25M | $36.01M | $40.96M | $39.19M | $40.40M | $35.40M | $40.70M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Total debt | $0 | $0 | $0 | $0 | $0 | — | — | — |
| Total liabilities | $64.04M | $55.83M | $54.25M | $55.04M | $54.23M | $78.12M | $74.61M | $81.33M |
| Shareholders' equity | $227.25M | $223.84M | $217.87M | $218.90M | $204.95M | $194.93M | $205.63M | $216.60M |
| Net debt | -$75.11M | -$69.85M | -$74.99M | -$83.45M | -$65.97M | — | — | — |
| Shares outstanding | 22.50M | 22.70M | 22.71M | 22.44M | 22.34M | 22.29M | 23.58M | 23.88M |
| Cash flow statement | ||||||||
| Operating cash flow | $11.98M | $3.25M | -$339,000 | $17.30M | $10.34M | $14.76M | $417,000 | $16.33M |
| Capital expenditure | $553,000 | $1.28M | $821,000 | $510,000 | $1.12M | $369,000 | $379,000 | $460,000 |
| Free cash flow | $11.43M | $1.97M | -$1.16M | $16.79M | $9.22M | $14.39M | $38,000 | $15.87M |
| Investing cash flow | -$601,000 | -$4.32M | -$7.06M | -$577,000 | -$1.15M | -$397,000 | -$407,000 | -$492,000 |
| Financing cash flow | -$6.12M | -$4.08M | -$1.05M | $762,000 | -$24.75M | -$16.45M | -$10.76M | -$3.62M |
| Depreciation & amortization | $1.77M | $1.81M | $1.64M | $1.62M | $1.64M | $1.66M | $1.73M | $1.71M |
| Stock-based compensation | $2.38M | $2.26M | $1.78M | $2.54M | $1.81M | $1.94M | $2.07M | $1.85M |
| Share buybacks | $6.17M | $5.28M | $1.07M | -$1,000 | $0 | $16.54M | $10.02M | — |
Free plan shows the latest 8 periods; Pro shows all 47 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.